BOSTON SCIENTIFIC CORP (BSX.DE) Stock Fundamental Analysis
Europe • Frankfurt Stock Exchange • FRA:BSX • US1011371077
78 EUR
+0.6 (+0.78%)
Last: Jan 30, 2026, 07:00 PM
BSX gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 68 industry peers in the Health Care Equipment & Supplies industry. While BSX has a great profitability rating, there are some minor concerns on its financial health. BSX shows excellent growth, but is valued quite expensive already.
1. Profitability
1.1 Basic Checks
- In the past year BSX was profitable.
- BSX had a positive operating cash flow in the past year.
- BSX had positive earnings in 4 of the past 5 years.
- BSX had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- Looking at the Return On Assets, with a value of 6.54%, BSX is in the better half of the industry, outperforming 73.53% of the companies in the same industry.
- Looking at the Return On Equity, with a value of 11.93%, BSX is in the better half of the industry, outperforming 70.59% of the companies in the same industry.
- BSX's Return On Invested Capital of 8.09% is fine compared to the rest of the industry. BSX outperforms 69.12% of its industry peers.
- Measured over the past 3 years, the Average Return On Invested Capital for BSX is below the industry average of 9.62%.
- The last Return On Invested Capital (8.09%) for BSX is above the 3 year average (6.59%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.54% | ||
| ROE | 11.93% | ||
| ROIC | 8.09% |
ROA(3y)3.72%
ROA(5y)2.77%
ROE(3y)6.77%
ROE(5y)5.1%
ROIC(3y)6.59%
ROIC(5y)5.7%
1.3 Margins
- BSX has a Profit Margin of 14.42%. This is amongst the best in the industry. BSX outperforms 82.35% of its industry peers.
- BSX's Profit Margin has declined in the last couple of years.
- Looking at the Operating Margin, with a value of 19.40%, BSX belongs to the top of the industry, outperforming 80.88% of the companies in the same industry.
- BSX's Operating Margin has been stable in the last couple of years.
- BSX has a Gross Margin of 68.57%. This is in the better half of the industry: BSX outperforms 76.47% of its industry peers.
- In the last couple of years the Gross Margin of BSX has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 19.4% | ||
| PM (TTM) | 14.42% | ||
| GM | 68.57% |
OM growth 3Y0.91%
OM growth 5Y1.48%
PM growth 3Y10.12%
PM growth 5Y-24.05%
GM growth 3Y-0.15%
GM growth 5Y-0.56%
2. Health
2.1 Basic Checks
- BSX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
- The number of shares outstanding for BSX has been increased compared to 1 year ago.
- BSX has more shares outstanding than it did 5 years ago.
- The debt/assets ratio for BSX is higher compared to a year ago.
2.2 Solvency
- BSX has an Altman-Z score of 5.26. This indicates that BSX is financially healthy and has little risk of bankruptcy at the moment.
- BSX has a Altman-Z score of 5.26. This is amongst the best in the industry. BSX outperforms 86.76% of its industry peers.
- The Debt to FCF ratio of BSX is 3.03, which is a good value as it means it would take BSX, 3.03 years of fcf income to pay off all of its debts.
- BSX has a Debt to FCF ratio of 3.03. This is in the better half of the industry: BSX outperforms 73.53% of its industry peers.
- A Debt/Equity ratio of 0.48 indicates that BSX is not too dependend on debt financing.
- BSX has a Debt to Equity ratio (0.48) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.48 | ||
| Debt/FCF | 3.03 | ||
| Altman-Z | 5.26 |
ROIC/WACC0.82
WACC9.85%
2.3 Liquidity
- BSX has a Current Ratio of 1.51. This is a normal value and indicates that BSX is financially healthy and should not expect problems in meeting its short term obligations.
- BSX has a Current ratio (1.51) which is comparable to the rest of the industry.
- A Quick Ratio of 0.96 indicates that BSX may have some problems paying its short term obligations.
- Looking at the Quick ratio, with a value of 0.96, BSX is doing worse than 60.29% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.51 | ||
| Quick Ratio | 0.96 |
3. Growth
3.1 Past
- BSX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 25.00%, which is quite impressive.
- BSX shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 9.56% yearly.
- The Revenue has grown by 21.62% in the past year. This is a very strong growth!
- BSX shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.30% yearly.
EPS 1Y (TTM)25%
EPS 3Y15.48%
EPS 5Y9.56%
EPS Q2Q%19.05%
Revenue 1Y (TTM)21.62%
Revenue growth 3Y12.1%
Revenue growth 5Y9.3%
Sales Q2Q%20.34%
3.2 Future
- The Earnings Per Share is expected to grow by 15.06% on average over the next years. This is quite good.
- BSX is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 12.60% yearly.
EPS Next Y22.12%
EPS Next 2Y18.13%
EPS Next 3Y16.37%
EPS Next 5Y15.06%
Revenue Next Year20.92%
Revenue Next 2Y16.08%
Revenue Next 3Y14.31%
Revenue Next 5Y12.6%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
- BSX is valuated quite expensively with a Price/Earnings ratio of 31.45.
- The rest of the industry has a similar Price/Earnings ratio as BSX.
- BSX's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 28.32.
- A Price/Forward Earnings ratio of 26.54 indicates a quite expensive valuation of BSX.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of BSX is on the same level as its industry peers.
- When comparing the Price/Forward Earnings ratio of BSX to the average of the S&P500 Index (25.57), we can say BSX is valued inline with the index average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 31.45 | ||
| Fwd PE | 26.54 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, BSX is valued a bit more expensive than the industry average as 67.65% of the companies are valued more cheaply.
- BSX's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 36.05 | ||
| EV/EBITDA | 29.02 |
4.3 Compensation for Growth
- The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
- The decent profitability rating of BSX may justify a higher PE ratio.
- A more expensive valuation may be justified as BSX's earnings are expected to grow with 16.37% in the coming years.
PEG (NY)1.42
PEG (5Y)3.29
EPS Next 2Y18.13%
EPS Next 3Y16.37%
5. Dividend
5.1 Amount
- BSX does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
BOSTON SCIENTIFIC CORP / BSX.DE FAQ
What is the ChartMill fundamental rating of BOSTON SCIENTIFIC CORP (BSX.DE) stock?
ChartMill assigns a fundamental rating of 6 / 10 to BSX.DE.
What is the valuation status for BSX stock?
ChartMill assigns a valuation rating of 3 / 10 to BOSTON SCIENTIFIC CORP (BSX.DE). This can be considered as Overvalued.
How profitable is BOSTON SCIENTIFIC CORP (BSX.DE) stock?
BOSTON SCIENTIFIC CORP (BSX.DE) has a profitability rating of 7 / 10.
What is the valuation of BOSTON SCIENTIFIC CORP based on its PE and PB ratios?
The Price/Earnings (PE) ratio for BOSTON SCIENTIFIC CORP (BSX.DE) is 31.45 and the Price/Book (PB) ratio is 5.89.
Can you provide the expected EPS growth for BSX stock?
The Earnings per Share (EPS) of BOSTON SCIENTIFIC CORP (BSX.DE) is expected to grow by 22.12% in the next year.